跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,852 条关于
“Corcept Therapeutics Netherlands B.V.”
全部
18,852
临床试验
5,003
药物
3,260
机构
1,361
资讯
9,228
昨天
CHMP Backs 12 New Medicines, Including First Oral Daily Hidradenitis Suppurativa Option and Earlier-Line Tecvayli
去年
Corcept's Relacorilant Shows Promise in Cushing's Syndrome Treatment
去年
Corcept Therapeutics Submits New Drug Application for Relacorilant to Treat Cushing's Syndrome
去年
Relacorilant Shows Durable Cardiometabolic Benefits in Cushing's Syndrome Patients
上个月
Alfasigma to Acquire Nordic Group B.V., Expanding Specialty Care Portfolio and European Presence
2年前
Norgine Seeks Approval for Eflornithine in High-Risk Neuroblastoma via Project Orbis
2年前
Corcept Completes Enrollment in Phase III Ovarian Cancer Study of Relacorilant
9个月前
Biocon Launches GLP-1 Liraglutide in Netherlands, Marking First EU Direct Brand Launch
6个月前
GenScript Opens First European mRNA Production Facility in Netherlands
去年
Relacorilant Fails to Meet Primary Endpoint in GRADIENT Trial for Cushing's Syndrome
第 1 页，共 923 页
上一页
下一页
